Aytu Biopharma (AYTU) Accumulated Expenses (2013 - 2026)
Aytu Biopharma (AYTU) posted Accumulated Expenses of $35.21 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 7.8% from $38.16 million a year earlier but up 2.7% from the prior quarter.
Aytu Biopharma (AYTU) Accumulated Expenses (2013 - 2026) Analysis & Trends
Since fiscal Q4 2013, Aytu Biopharma has reported Accumulated Expenses for 43 quarters.
- Annual Accumulated Expenses shows a five-year compound annual growth rate of -9.3% (FY2021 to FY2026).
- In prior fiscal years, Aytu Biopharma's Accumulated Expenses was $38.16 million in FY2025 (+0.1%), $38.14 million in FY2024 (-18.5%), $46.8 million in FY2023 (+5.9%) and $44.19 million in FY2022 (-22.8%).
- Quarterly Accumulated Expenses has run from a low of $33.72 million in fiscal Q1 2025 to a high of $54.38 million in fiscal Q1 2022 over five years.
- On a year-over-year basis, Accumulated Expenses increased in three of the last eight quarters, with an average decline of 5.8%.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was fiscal Q1 2022, with growth of 525.6%; the weakest was fiscal Q1 2023, with a decline of 23.8%.
- According to Business Quant data, Accumulated Expenses for the three prior fiscal quarters was $34.27 million (Q3 2026), $40.16 million (Q2 2026) and $36.7 million (Q1 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Aytu Biopharma | 23.25 Mn | -92.42 Mn | 10.41 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.21 Mn |
| Mar 31, 2026 | 34.27 Mn |
| Dec 31, 2025 | 40.16 Mn |
| Sep 30, 2025 | 36.70 Mn |
| Jun 30, 2025 | 38.16 Mn |
| Mar 31, 2025 | 41.73 Mn |
| Dec 31, 2024 | 39.37 Mn |
| Sep 30, 2024 | 33.72 Mn |
| Jun 30, 2024 | 38.14 Mn |
| Mar 31, 2024 | 44.09 Mn |
| Dec 31, 2023 | 43.41 Mn |
| Sep 30, 2023 | 40.73 Mn |
| Jun 30, 2023 | 46.80 Mn |
| Mar 31, 2023 | 49.59 Mn |
| Dec 31, 2022 | 41.22 Mn |
| Sep 30, 2022 | 41.43 Mn |
| Jun 30, 2022 | 44.19 Mn |
| Mar 31, 2022 | 53.47 Mn |
| Dec 31, 2021 | 50.69 Mn |
| Sep 30, 2021 | 54.38 Mn |
Aytu Biopharma Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AYTU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();